Patents by Inventor Anthrogenesis Corporation

Anthrogenesis Corporation has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130315875
    Abstract: Provided herein are novel angiogenic cells from amnion, referred to as amnion derived adherent cells, and populations of, and compositions comprising, such cells. Further provided herein are methods of obtaining such cells and methods of using the cells in the treatment of individuals.
    Type: Application
    Filed: December 26, 2012
    Publication date: November 28, 2013
    Applicant: Anthrogenesis Corporation
    Inventor: Anthrogenesis Corporation
  • Publication number: 20130184821
    Abstract: The present invention provides a method of treating a leg ulcer comprising contacting the leg ulcer with a collagen biofabric. The leg ulcer may be a venous, arterial, diabetic or decubitus (pressure) ulcer. The invention further provides kits comprising one or more pieces of collagen biofabric for the treatment of a leg ulcer.
    Type: Application
    Filed: December 11, 2012
    Publication date: July 18, 2013
    Applicant: Anthrogenesis Corporation
    Inventor: Anthrogenesis Corporation
  • Publication number: 20130172531
    Abstract: The present invention provides compositions comprising human placental telopeptide collagen, methods of preparing the compositions, methods of their use and kits comprising the compositions. The compositions, kits and methods are useful, for example, for augmenting or replacing tissue of a mammal.
    Type: Application
    Filed: February 26, 2013
    Publication date: July 4, 2013
    Applicant: Anthrogenesis Corporation
    Inventor: Anthrogenesis Corporation